Pharmaxis Sues U.S. Investor For Withdrawing $20 Million Loan
This article was originally published in PharmAsia News
Executive Summary
Pharmaxis said it is suing one of its U.S. investors for withdrawing a U.S.$20 million loan in support of a trial of the Australian drug maker's Bronchitol (mannitol) for treating cystic fibrosis.